162 related articles for article (PubMed ID: 18437726)
1. Cardiac-resynchronization therapy.
Miljoen H; Paelinck BP; Vrints CJ
N Engl J Med; 2008 Apr; 358(17):1865; author reply 1865-6. PubMed ID: 18437726
[No Abstract] [Full Text] [Related]
2. Cardiac-resynchronization therapy.
Daubert C; Leclercq C
N Engl J Med; 2008 Apr; 358(17):1865; author reply 1865-6. PubMed ID: 18434658
[No Abstract] [Full Text] [Related]
3. Cardiac resynchronization therapy--who benefits? Separating myths from facts.
Deshpande S; Tol S; Lokhandwala Y
Indian Heart J; 2007; 59(1 Suppl A):A57-62. PubMed ID: 19104133
[No Abstract] [Full Text] [Related]
4. Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dyssynchrony.
Abraham WT
Circulation; 2006 Dec; 114(24):2692-8; discussion 2698. PubMed ID: 17159075
[No Abstract] [Full Text] [Related]
5. All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy.
Greenberg B; Mehra MR
Circulation; 2006 Dec; 114(24):2685-90; discussion 2691. PubMed ID: 17159074
[No Abstract] [Full Text] [Related]
6. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
7. Update on the pathophysiological basics of cardiac resynchronization therapy.
Auricchio A; Prinzen FW
Europace; 2008 Jul; 10(7):797-800. PubMed ID: 18482999
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy.
Breithardt OA
J Am Coll Cardiol; 2007 May; 49(18):1899; author reply 1899-900. PubMed ID: 17481450
[No Abstract] [Full Text] [Related]
9. Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier?
Maass AH; van Veldhuisen DJ
Eur J Heart Fail; 2010 Jun; 12(6):527-9. PubMed ID: 20498266
[No Abstract] [Full Text] [Related]
10. Re: "Effects of cardiac resynchronization therapy on heart rate turbulence".
Gademan MG; Swenne CA
Pacing Clin Electrophysiol; 2009 Jul; 32(7):964; author reply 964-5. PubMed ID: 19572883
[No Abstract] [Full Text] [Related]
11. Cardiac resynchronization therapy in the young patient: current status and future directions.
Serwer GA
J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1072-3. PubMed ID: 16899056
[No Abstract] [Full Text] [Related]
12. Electrocardiography and resynchronization therapy: is the QRS duration sufficient?
Alberola AG
Rev Esp Cardiol; 2008 Dec; 61(12):1236-8. PubMed ID: 19080960
[No Abstract] [Full Text] [Related]
13. ECG of the month. To lead or to mislead? Pacemaker rhythm.
Martinez-Lopez JI
J La State Med Soc; 1994 Aug; 146(8):333-6. PubMed ID: 7930862
[No Abstract] [Full Text] [Related]
14. Cardiac resynchronization therapy: the more pacing sites, the better the outcome?
Auricchio A; Prinzen FW
J Am Coll Cardiol; 2008 Apr; 51(15):1463-5. PubMed ID: 18402901
[No Abstract] [Full Text] [Related]
15. Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay.
Alonso C; Ritter P; Leclercq C; Mabo P; Bailleul C; Daubert JC;
Am J Cardiol; 2003 May; 91(9):1144-7. PubMed ID: 12714168
[No Abstract] [Full Text] [Related]
16. [European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association].
Vardas PE; Auricchio A; Blanc JJ; Daubert JC; Drexler H; Ector H; Gasparini M; Linde C; Bello Morgado F; Oto A; Sutton R; Trusz-Gluza M;
Rev Esp Cardiol; 2007 Dec; 60(12):1272.e1-1272.e51. PubMed ID: 18082093
[No Abstract] [Full Text] [Related]
17. Cardiac resynchronization therapy and the arrhythmogenic substrate.
Lux RL; Hamdan MH
J Cardiovasc Electrophysiol; 2005 Jun; 16(6):618-9. PubMed ID: 15946360
[No Abstract] [Full Text] [Related]
18. Use of cardiac resynchronization therapy in the context of electrocardiographic criteria needs reconsideration.
Patnaik UK
Indian Heart J; 2004; 56(2):177; author reply 177-8. PubMed ID: 15377146
[No Abstract] [Full Text] [Related]
19. Improvement of P wave dispersion after cardiac resynchronization therapy for heart failure.
Ding L; Hua W; Zhang S; Chu J; Chen K; Wang F; Chen X
J Electrocardiol; 2009; 42(4):334-8. PubMed ID: 19539810
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac resynchronization therapy: today's and tomorrow's indications].
Leclercq C
Ann Cardiol Angeiol (Paris); 2007 Sep; 56(4):163-7. PubMed ID: 17936453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
